...
首页> 外文期刊>Journal of Medicinal Chemistry >Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
【24h】

Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.

机译:1,4-苯并二恶烷相关化合物的构效关系。 6.二恶烷单元对α(1)-肾上腺素受体亚型选择性的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

WB 4101-related benzodioxans 3-9 were synthesized, and their biological profiles at alpha(1)-adrenoreceptor subtypes and 5-HT(1A) serotoninergic receptors were assessed by binding assays in CHO and HeLa cells membranes expressing the human cloned receptors. Furthermore, receptor selectivity of selected benzodioxan derivatives was further determined in functional experiments in isolated rat vas deferens (alpha(1A)) and aorta (alpha(1D)) and guinea pig spleen (alpha(1B)), in additional receptor binding assays in rat cortex membranes containing alpha(2)-adrenoreceptors and 5-HT(2) serotoninergic receptors, and in rat striatum membranes containing D(2) dopaminergic receptors. An analysis of the results of receptor binding experiments for benzodioxan-modified derivatives 3-9 showed high affinity and selectivity toward the alpha(1a)-adrenoreceptor subtype for compounds 3-5 and 7 and a reversed selectivity profile for 9, which was a selective alpha(1d) antagonist. Furthermore, the majority of structural modifications performed on the prototype 1 (WB 4101) led to a marked decrease in the affinity for 5-HT(1A) serotoninergic receptors, which may have relevance in the design of selective alpha(1A)-adrenoreceptor antagonists. The exception to these findings was the chromene derivative 8, which exhibited a 5-HT(1A) partial agonist profile.
机译:合成了WB 4101相关的苯并二恶烷3-9,并通过表达人克隆受体的CHO和HeLa细胞膜中的结合测定法评估了其在α(1)-肾上腺素受体亚型和5-HT(1A)5-羟色胺能受体上的生物学特性。此外,在功能性实验中,在分离的大鼠输精管(alpha(1A))和主动脉(alpha(1D))和豚鼠脾脏(alpha(1B))中进行了功能性实验,进一步确定了所选苯并二恶烷衍生物的受体选择性。大鼠皮层膜含有α(2)-肾上腺素能受体和5-HT(2)血清素能受体,在大鼠纹状体膜中含有D(2)多巴胺能受体。苯并二恶烷改性的衍生物3-9的受体结合实验结果分析表明,化合物3-5和7对α(1a)-肾上腺素受体亚型具有高亲和力和选择性,而对9的选择性则相反,这是选择性的alpha(1d)拮抗剂。此外,对原型1(WB 4101)进行的大多数结构修饰导致对5-HT(1A)5-羟色胺能受体的亲和力显着降低,这可能与选择性α(1A)-肾上腺素受体拮抗剂的设计有关。这些发现的例外是色烯衍生物8,其表现出5-HT(1A)部分激动剂谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号